Expression, crystallization, and three-dimensional structure of the catalytic domain of human plasma kallikrein (Q42039620)

15 October 2017

Expression, crystallization, and three-dimensional structure of the catalytic domain of human plasma kallikrein (English)

1 reference

15 October 2017

7

Alberto Estevez

1 reference

15 October 2017

Jie Tang

1

1 reference

15 October 2017

Christine Luong Yu

2

1 reference

15 October 2017

Steven R Williams

3

1 reference

15 October 2017

Eric Springman

4

1 reference

15 October 2017

Douglas Jeffery

5

1 reference

15 October 2017

Paul A Sprengeler

6

1 reference

15 October 2017

Jun Sampang

8

1 reference

15 October 2017

William Shrader

9

1 reference

15 October 2017

Jeff Spencer

10

1 reference

15 October 2017

Wendy Young

11

1 reference

15 October 2017

Mary McGrath

12

1 reference

15 October 2017

Bradley A Katz

13

1 reference

15 October 2017

language of work or name

English

0 references

publication date

30 September 2005

1 reference

Journal of Biological Chemistry

15 October 2017

13

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

15 October 2017

280

1 reference

15 October 2017

49

1 reference

15 October 2017

41077-41089

1 reference

The new human tissue kallikrein gene family: structure, function, and association to disease.

15 October 2017

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M506766200

Plasma prekallikrein: isolation, characterization, and mechanism of activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M506766200

Human plasma prekallikrein, a zymogen to a serine protease that contains four tandem repeats

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M506766200

The emerging roles of human tissue kallikreins in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M506766200

Extra-hepatic transcription of plasma prekallikrein gene in human and rat tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M506766200

Identification of prekallikrein and high-molecular-weight kininogen as a complex in human plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M506766200

Identification of cytokeratin 1 as a binding protein and presentation receptor for kininogens on endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M506766200

Binding of high molecular weight kininogen to human endothelial cells is mediated via a site within domains 2 and 3 of the urokinase receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M506766200

Isolation and characterization of the kininogen-binding protein p33 from endothelial cells. Identity with the gC1q receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M506766200

Identification of the zinc-dependent endothelial cell binding protein for high molecular weight kininogen and factor XII: identity with the receptor that binds to the globular "heads" of C1q (gC1q-R)

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M506766200

Expression and colocalization of cytokeratin 1 and urokinase plasminogen activator receptor on endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M506766200

Identification and characterization of prolylcarboxypeptidase as an endothelial cell prekallikrein activator

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M506766200

The plasma kallikrein/kinin and renin angiotensin systems in blood pressure regulation in sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M506766200

Plasma kallikrein/kinin system: a revised hypothesis for its activation and its physiologic contributions

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M506766200

A prealbumin activator of prekallikrein. 3. Appearance of chemotactic activity for human neutrophils by the conversion of human prekallikrein to kallikrein

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M506766200

Human plasma kallikrein releases neutrophil elastase during blood coagulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M506766200

Development of the proteasome inhibitor Velcade (Bortezomib).

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M506766200

Inhibitors of serine proteases as potential therapeutic agents: the road from thrombin to tryptase to cathepsin G.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M506766200

The presence of heparin-platelet factor 4 antibodies as a marker of hypercoagulability during hemodialysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M506766200

Hemorrhagic complications of anticoagulant treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M506766200

On the size of the active site in proteases. I. Papain

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M506766200

The crystal structure of the complex of blood coagulation factor VIIa with soluble tissue factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M506766200

Design, parallel synthesis, and crystal structures of pyrazinone antithrombotics as selective inhibitors of the tissue factor VIIa complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M506766200

X-ray structure of active site-inhibited clotting factor Xa. Implications for drug design and substrate recognition

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M506766200

Structure-based design of potent, amidine-derived inhibitors of factor Xa: evaluation of selectivity, anticoagulant activity, and antithrombotic activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M506766200

The use of 3D structural data in the design of specific factor Xa inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M506766200

Complement. First of two parts

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M506766200

Plasma and tissue kallikrein in arthritis and inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M506766200

Increased vascular permeability in C1 inhibitor-deficient mice mediated by the bradykinin type 2 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M506766200

1.70 A X-ray structure of human apo kallikrein 1: structural changes upon peptide inhibitor/substrate binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M506766200

Crystal structure and biochemical characterization of human kallikrein 6 reveals that a trypsin-like kallikrein is expressed in the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M506766200

The structure of human prokallikrein 6 reveals a novel activation mechanism for the kallikrein family

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M506766200

Structural basis for selectivity of a small molecule, S1-binding, submicromolar inhibitor of urokinase-type plasminogen activator

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M506766200

High-throughput screening of enzyme inhibitors: automatic determination of tight-binding inhibition constants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M506766200

Crystal structures of the FXIa catalytic domain in complex with ecotin mutants reveal substrate-like interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M506766200

Hold tight (but not too tight) to get it right: accurate bypass of an 8-oxoguanine lesion by DNA polymerase beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M506766200

21 January 2018

The Protein Data Bank

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M506766200

ARP/wARP and molecular replacement

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M506766200

Free R value: a novel statistical quantity for assessing the accuracy of crystal structures

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M506766200

Development of serine protease inhibitors displaying a multicentered short (<2.3 A) hydrogen bond binding mode: inhibitors of urokinase-type plasminogen activator and factor Xa.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M506766200

Exploiting subsite S1 of trypsin-like serine proteases for selectivity: potent and selective inhibitors of urokinase-type plasminogen activator

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M506766200

2-(2-Hydroxy-3-alkoxyphenyl)-1H-benzimidazole-5-carboxamidine derivatives as potent and selective urokinase-type plasminogen activator inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M506766200

Contribution of multicentered short hydrogen bond arrays to potency of active site-directed serine protease inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M506766200

Engineering inhibitors highly selective for the S1 sites of Ser190 trypsin-like serine protease drug targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M506766200

Dissecting and designing inhibitor selectivity determinants at the S1 site using an artificial Ala190 protease (Ala190 uPA)

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M506766200

Role of loop structures of neuropsin in the activity of serine protease and regulated secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M506766200

A single gene for bovine high molecular weight and low molecular weight kininogens

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M506766200

Rapid and general profiling of protease specificity by using combinatorial fluorogenic substrate libraries

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M506766200

Mapping the active sites of bovine thrombin, factor IXa, factor Xa, factor XIa, factor XIIa, plasma kallikrein, and trypsin with amino acid and peptide thioesters: development of new sensitive substrates

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M506766200

Der Nachweis eines Kreislaufhormons in der Pankreasdrüse. (IV. Mitteilung über dieses Kreislaufhormon.)

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M506766200

21 January 2018

Identifiers

DOI

10.1074/JBC.M506766200

1 reference

15 October 2017

1 reference